Novartis India Q1, Q2, Q3, Q4, FY 2017-18, FY 2016-17 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Novartis India Company Profile :

Novartis India Limited is an Indian based holding company engaged in the business of wholesale of pharmaceuticals and medical goods including drugs, medicines and allied products with a focus on over three divisions, including pharmaceuticals, eye care and generic medicines. Company’s geographical segments include India and Other Countries.

Pharmaceutical segment is focused on bone and pain, calcium portfolio, gynecology, neurosciences, development and commercialization in oncology, primary care and specialty medicines.

Generics segment comprises retail generics products with a primary focuses on the therapeutic segments, such as anti-tuberculosis (TB), anti-dysfunctional uterine bleeding (DUB (Gynecology)), antihistamines, antibiotics, anti-ulcerants, anti-diabetes and cardiovascular.


Novartis India ResultsBSE Code : 500672
NSE Symbol :
ISIN No. : INE234A01025
Industry :  Pharmaceuticals
Face Value : Rs. 5.00


If you are an investor who has shares of Novartis India or you are an stock market analyst then i am sure you might for Quarterly Results of Novartis India.

In this article you will find Q1, Q2, Q3, Q4 and FY 2017-18 Results of Novartis India. That’s not all, you can compare those results with previous year i.e., FY 2016-17 Results of Novartis India.

Novartis India Q1 Results 2016-17 :

Novartis India will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Novartis India will announce its Q2 FY 2016-17 Results in the month of October 2016.

Novartis India will announce its Q3 FY 2016-17 Results in the month of January 2017.

Novartis India will announce its Q4 FY 2016-17 Results in the month of April 2017.

Novartis India will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

Novartis India Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 808.32
Other Income  82.94
Total Income  891.26
Expenditure  -784.90
Interest  -0.18
Depreciation  -3.67
PBT  102.51
Tax -35.80
Net Profit  198.61
Equity  15.98
EPS  62.14

Note : If you like this information about Novartis India Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.